In situ delivery and production system (iDPS) of anti-cancer molecules with gene-engineered bifidobacterium. Probiotic strains detect and suppress cholera in mice. Engineered lactobacilli display anti-biofilm and growth suppressing activities against Pseudomonas aeruginosa. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. ![]() CRISPR interference for rapid knockdown of essential cell cycle genes in Lactobacillus plantarum. Development of a RecE/T-assisted CRISPR–Cas9 toolbox for Lactobacillus. Portable CRISPR-Cas9(N) system for flexible genome engineering in Lactobacillus acidophilus, Lactobacillus gasseri, and Lactobacillus paracasei. CRISPR/Cas9-assisted seamless genome editing in Lactobacillus plantarum and its application in N-acetylglucosamine production. Genome editing using the endogenous type I CRISPR–Cas system in Lactobacillus crispatus. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study. Safety and pharmacodynamics of an engineered E. Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering. Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Guild-based analysis for understanding gut microbiome in human health and diseases. Engineered bacteria as therapeutic agents. The gut microbiota - masters of host development and physiology. Structure, function and diversity of the healthy human microbiome. Massive expansion of human gut bacteriophage diversity. F., Almeida, A., Rangel-Pineros, G., Finn, R. Emerging technologies for gut microbiome research. Brain–gut–microbe communication in health and disease. Microbes in gastrointestinal health and disease. Understanding the holobiont: how microbial metabolites affect human health and shape the immune system. Urbanization and the gut microbiota in health and inflammatory bowel disease. This article reviews the role of the gut microbiome in human health and disease. The human intestinal microbiome in health and disease. Discover your life-changing career at University Health.Lynch, S. ![]() The generous benefits packages, coaching program and continuing education offered at University Health all create a satisfied employee environment, translating into the best patient care. University Health is committed to providing the best workplace environment. Our advancement of medical knowledge through clinical research, our massive expansion and our ranking as one of the best hospitals in South Texas have created a critical need for the best, highly qualified individuals to join our team. We are the future of health care, making a difference in the lives of our patients. Our Magnet designation for nursing excellence, our Level I trauma center and the teamwork approach in a teaching hospital environment prove that. And many employees gladly commute long distances for a rewarding career at University Health. Many of our long-term employees could work anywhere, but choose us. University Health is one of the largest employers in San Antonio, with more than 8,000 employees and more than 900 physicians and residents. View our latest job fairs and sign up today! Your Future, Your Career University Health is looking for highly qualified personnel to join our team.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |